Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Myeloid 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 151Leukemia 138Leukemia, Myeloid, Acute 127Myelodysplastic Syndromes 106Precursor Cell Lymphoblastic Leukemia-Lymphoma 103Lymphoma 87Lymphoma, Non-Hodgkin 86Multiple Myeloma 84Hodgkin Disease 81Lymphoma, Mantle-Cell 71Lymphoma, Follicular 68Lymphoma, Large B-Cell, Diffuse 60Congenital Abnormalities 59Myeloproliferative Disorders 58Lymphoma, B-Cell, Marginal Zone 58Leukemia, Myeloid, Chronic-Phase 56Leukemia, Myelomonocytic, Chronic 52Leukemia, Myeloid, Accelerated Phase 50Burkitt Lymphoma 50Leukemia, Myelogenous, Chronic, BCR-ABL Positive 46Lymphoma, Large-Cell, Immunoblastic 43Anemia, Refractory, with Excess of Blasts 42Waldenstrom Macroglobulinemia 41Blast Crisis 40Primary Myelofibrosis 38Melanoma 35Recurrence 34Neoplasms, Plasma Cell 34Dendritic Cell Sarcoma, Interdigitating 30Lymphoma, T-Cell, Cutaneous 29

Interventions

Imatinib Mesylate 13bosutinib 3Vincristine 3Dexamethasone 3Dasatinib 3Cyclophosphamide 3nilotinib 2fludarabine phosphate 2fludarabine 2Methotrexate 2Daunorubicin 2Cytarabine 2Azacitidine 2Acetaminophen 24-methyl-N-(3-(4-methylimidazol-1-yl)-5-trifluoromethylphenyl)-3-(4-pyrazin-2-ylpyrimidin-2-ylamino)benzamide 2venetoclax 1thymoglobulin 1peginterferon alfa-2a 1flumatinib 1Whole-Body Irradiation 1Tyrosine Kinase Inhibitors 1Tacrolimus 1Rituximab 1Prednisone 1Prednisolone 1Mycophenolic Acid 1Mitoxantrone 1Mercaptopurine 1Melphalan 1Magnetic Resonance Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Philadelphia Chromosome × fludarabine phosphate × Clear all
NCT03448393 2025-06-04

CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
54 enrolled 24 charts
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Lymphoma, Non-Hodgkin, Philadelphia Chromosome, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01471067 2017-04-28

Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies

M.D. Anderson Cancer Center

Phase 1 Completed
33 enrolled
LymphoidMyeloidOther hematologic neoplasm

Pathologic Complete Response, Histiocytosis, Langerhans-Cell, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Philadelphia Chromosome, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡